Buy Stocks Easy | About Us

September 25, 2021

CYAD

Buy Celyad SA Stock (symbol: CYAD) Easy Online

Company Name: Celyad SA

Symbol: CYAD

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2015

CYAD Current Share Price

Today's CYAD ( Celyad SA ) opening price: $9.7200

Yesterday's CYAD ( Celyad SA ) closing price: $9.8200

Celyad SA Stock ( symbol: CYAD ) Price Chart since IPO (2015):

12 Months Celyad SA Stock ( symbol: CYAD ) Price Chart

Popular Questions about Celyad SA Public Stock ( CYAD )

A: Celyad SA stock symbol (also called stock or share ticker) is CYAD

A: Celyad SA IPO (Initial Public Offering) took place on 2015

A: Celyad SA's stock (CYAD symbol) price at ther IPO (initial Public Offering) was $9.7200

Q: Is CYAD stock worth buying at the moment?

A: The CYAD stock performance since 2019 are rather disappointing. If you had bought 1 share of Celyad SA stock (symbol: CYAD) at the beginning of 2019, at the opening share price of $21.6000, you would be left with exactly $9.7200 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Celyad SA Stock Easy Online

Celyad SA Stock Ticker Price Chart since IPO:

Celyad SA Stock Price Yesterday

Celyad SA Stock Price – Last Week

Celyad SA Stock Price – Last Month

Celyad SA Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

http://www.globenewswire.com/news-release/2019/11/29/1953829/0/en/Celyad-Announces-Board-of-Directors-Evolution-with-New-Appointment.html

Celyad Announces Board of Directors Evolution with New Appointment

MONT-SAINT-GUIBERT, Belgium, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Ce...

http://www.globenewswire.com/news-release/2019/11/22/1951192/0/en/Celyad-Receives-8-5-Million-in-Grants-and-Non-Dilutive-Funding-by-the-Walloon-Region.html

Celyad Receives €8.5 Million in Grants and Non-Dilutive Funding by the Walloon Region

MONT-SAINT-GUIBERT, Belgium, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Ce...

http://www.zacks.com/stock/news/617672/celyad-sa-cyad-moves-to-buy-rationale-behind-the-upgrade

Celyad SA (CYAD) Moves to Buy: Rationale Behind the Upgrade

Celyad SA (CYAD) might move higher on growing optimism about its ea...

http://www.globenewswire.com/news-release/2019/11/11/1944433/0/en/Celyad-Highlights-Safety-and-Clinical-Activity-of-CYAD-101-a-First-In-Class-Non-Gene-Edited-Allogeneic-CAR-T-Therapy-for-mCRC-from-SITC-34th-Annual-Meeting.html

Celyad Highlights Safety and Clinical Activity of CYAD-101, a First-In-Class, Non-Gene Edited Allogeneic CAR-T Therapy for mCRC, from SITC 34th Annual Meeting

MONT-SAINT-GUIBERT, Belgium, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Ce...

http://www.globenewswire.com/news-release/2019/10/02/1923794/0/en/Celyad-Announces-October-and-November-2019-Investor-Conference-Schedule.html

Celyad Announces October and November 2019 Investor Conference Schedule

MONT-SAINT-GUIBERT, Belgium, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Ce...

http://www.globenewswire.com/news-release/2019/10/02/1923800/0/en/Celyad-to-Present-Update-on-mCRC-Clinical-Program-at-the-2019-SITC-Annual-Meeting.html

Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting

MONT-SAINT-GUIBERT, Belgium, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Ce...

http://www.globenewswire.com/news-release/2019/09/16/1916270/0/en/Celyad-Announces-Closing-of-20-Million-Global-Offering.html

Celyad Announces Closing of $20 Million Global Offering

MONT-SAINT-GUIBERT, Belgium, Sept. 16, 2019 (GLOBE NEWSWIRE) -- C...

http://www.globenewswire.com/news-release/2019/09/12/1914873/0/en/Celyad-Announces-Pricing-of-20-0-Million-Global-Offering.html

Celyad Announces Pricing of $20.0 Million Global Offering

MONT-SAINT-GUIBERT, Belgium, Sept. 12, 2019 (GLOBE NEWSWIRE) -- C...

http://www.globenewswire.com/news-release/2019/09/10/1913801/0/en/Celyad-Announces-Launch-of-Proposed-Global-Offering.html

Celyad Announces Launch of Proposed Global Offering

MONT-SAINT-GUIBERT, Belgium, Sept. 10, 2019 (GLOBE NEWSWIRE) -- C...

http://www.globenewswire.com/news-release/2019/09/04/1910491/0/en/Celyad-Successfully-Doses-First-Patient-with-CYAD-01-Produced-with-OptimAb-Manufacturing-Process.html

Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

MONT-SAINT-GUIBERT, Belgium, Sept. 04, 2019 (GLOBE NEWSWIRE) -- C...

All right reserved Buy Stocks Easy , 2019.